nivolumab vs ipilimumab for high risk melanoma patients
Published 6 years ago • 664 plays • Length 6:12Download video MP4
Download video MP3
Similar videos
-
4:59
adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with res...
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
2:48
checkmate067 outcomes: nivolumab plus ipilimumab in advanced melanoma
-
5:18
neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage iii melanoma
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
3:31
comment: adjuvant ipilimumab in high-risk melanoma
-
5:56
results from checkmate-032, nivolumab and ipilimumab for melanoma
-
6:51
success for ipilimumab and nivolumab combo in advanced melanoma
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
3:16
melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better pfs
-
5:52
nivolumab and salvage nivolumab plus ipilimumab for arcc
-
1:13
checkmate 067: nivolumab plus ipilimumab combination therapy in advanced melanoma
-
2:04
benefits and risks of reinduction ipilimumab/nivolumab in patients with melanoma
-
2:22
adjuvant nivolumab in patents with high-risk resected melanoma
-
1:18
comment: ipilimumab in high risk stage iii melanoma
-
2:54
combining nivolumab and ipilimumab in patients with resected stage iv melanoma
-
2:10
ipilimumab combined with nivolumab for patients with melanoma
-
5:04
high- vs low-dose pre-operative ipilimumab and nivolumab in locoregionally advanced urothelial c...
-
1:59
checkmate 238: nivolumab versus ipilimumab in stage iii melanoma